Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies

BACKGROUND: A cationic liposome-PEG-PEI complex (LPPC) was employed as a carrier for achieving targeted delivery of drug to human epidermal growth factor receptor-2 (HER2/neu)-expressing breast cancer cells. LPPC can be easily loaded with an anti-tumor drug and non-covalently associated with an anti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nanobiotechnology
Egile Nagusiak: Lin, Yu-Ling, Tsai, Nu-Man, Chen, Chia-Hung, Liu, Yen-Ku, Lee, Chung-Jen, Chan, Yi-Lin, Wang, Yu-Shan, Chang, Yuan-Ching, Lin, Chi-Hsin, Huang, Tse-Hung, Wang, Chao Ching, Chi, Kwan-Hwa, Liao, Kuang-Wen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364477/
https://ncbi.nlm.nih.gov/pubmed/30728015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-019-0457-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak